lottery ticket
Amazon has dropped a flurry of TV deals for Black Friday , including a major discount on this massive 77-Inch Samsung OLED 4K TV model that’s hard to beat. The 77-inch Samsung OLED 4K S95D Series HDR Pro Smart TV is now on sale for $3,498, instead of $4,398, for a savings of 20% off. This is huge $900 markdown on this 2024 Samsung TV in one of the best deals we’ve seen on this 77-inch model from Amazon. The 77-Inch Samsung OLED 4K S95D TV has it all, including an expansive screen with AI-powered 4K resolution and OLED technology for pure picture color and vivid detail. It also incorporates an anti-glare option for improved viewing with OLED HDR PRO to optimize picture quality. More features of the 77-Inch Samsung OLED 4K S95D TV include a Motion Xcelerator for video game play without lag or blur, while the Tizen OS provides access to your favorite streaming apps and more. You’ll also benefit from the built-in Dolby Atmos with 3D sound quality and voice control using Google Assistant and Alexa. Amazon is offering this Samsung TV deal with free scheduled Prime delivery. Shop for this 77-Inch Samsung OLED 4K TV deal on Amazon here. You can also check out more TVs on sale from Amazon for Black Friday , including these top models: Find even more markdowns on smart TVs during Amazon’s big Black Friday sale here. The Best Black Friday Deals in 2024 Our journalism needs your support. Please subscribe today to NJ.com . Dawn Magyar can be reached at dmagyar@njadvancemedia.com . Have a tip? Tell us at nj.com/tips/ .
Commerce Department to reduce Intel's funding on semiconductors
FOXBOROUGH, Mass. (AP) — The NFL removed New England Patriots safety Jabrill Peppers from the commissioner exempt list on Monday, making him eligible to participate in practice and play in the team’s games. Peppers missed seven games since being placed on the list on Oct. 9 after he was arrested and charged with shoving his girlfriend’s head into a wall and choking her. The league said its review is ongoing and is not affected by the change in Peppers’ roster status. Javascript is required for you to be able to read premium content. Please enable it in your browser settings.‘Relentlessly lying’: Elon Musk’s brutal response to Sydney Morning Herald prediction
Gal Gadot/instagram is opening up about a life-threatening health crisis she experienced while pregnant with her fourth child. The actress, 39, detailed the “terrifying” event in an on Sunday, Dec. 29, revealing that she was diagnosed with a “massive blood clot” in her brain during her eighth month of pregnancy. “For weeks, I had endured excruciating headaches that confined me to bed, until I finally underwent an MRI that revealed the terrifying truth,” the star wrote. “In one moment, my family and I were faced with how fragile life can be. It was a stark reminder of how quickly everything can change, and in the midst of a difficult year, all I wanted was to hold on and live.” Related: Gadot shared that she was rushed to the hospital where she underwent emergency surgery and also gave birth to her daughter Ori, now 9 months old, during the procedure in March. “Her name, meaning ‘my light,’ wasn’t chosen by chance," Gadot wrote of Ori. "Before the surgery, I told [my husband] Jaron that when our daughter arrived, she would be the light waiting for me at the end of this tunnel." Gadot then went on to thank the “extraordinary team of doctors” at Cedars Sinai in Los Angeles. Nina Westervelt/Variety via Getty Related: The actress — who wrote in the post that she is now “fully healed” — urged people to listen to their bodies. “Pain, discomfort or even subtle changes often carry a deeper meaning, and being attuned to your body can be life saving,” she continued, adding that “awareness matters.” “I had no idea that 3 in 100,000 pregnant women in the 30s+ age group are diagnosed with CVT (develop a blood clot in the brain). It’s so important to identify early because it’s treatable. While rare, it’s a possibility, and knowing it exists is the first step to addressing it," Gadot wrote. The mother of four reassured her fans that she did not intend to “frighten anyone" with her post, but rather hopes to “empower" them. “If even one person feels compelled to take action for their health because of this story, it will have been worth sharing,” she concluded, while noting that she hopes sharing her personal experience will pull “back the curtain on the fragile reality behind the curated moments we share on social media.” The actress also shared the post on her Instagram Stories and included a link to an about strokes from the American Heart Association. Todd Williamson/NBC/NBCU Photo Bank via Getty Related: Gadot initially announced the birth of her fourth child on in March, though she made no mention of the harrowing medical situation at the time. “My sweet girl, welcome,” Gadot captioned a photo of herself cradling Ori in a hospital bed at the time. “The pregnancy was not easy and we made it through," she continued, adding, "You have brought so much light into our lives, living up to your name, Ori, which means ‘my light’ in Hebrew. Our hearts are full of gratitude. Welcome to the house of girls.. 👯♀️👯♀️ daddy is pretty cool too 😉❤️." Gadot, who is married to film producer , is also mom to Alma, 13, Maya, 7, and Daniella, 3. Read the original article onNone
1 2 3 Nagpur: CSIR-Neeri emphasised the importance of institutionalising wastewater surveillance for coronaviruses (SarsCov2) through the World Health Organisation (WHO) Coronavirus Network (CoViNet) initiative during an international meeting supported by the United States Agency for International Development (USAID) and Program for Appropriate Technology in Health (PATH) in Ukraine on Monday. IPL 2025 mega auction IPL Auction 2025: Who went where and for how much IPL 2025: Complete list of players of each franchise CoViNet is an initiative to enhance global efforts in tracking emerging SarsCov2 variants , MERS and other coronaviruses. Dr Krishna Khairnar, principal scientist and head of environmental epidemiology at Neeri, made a virtual presentation during the seminar on ‘Fundamentals of Epidemiological Surveillance of Wastewater'. During a talk on ‘Environmental Surveillance of Coronaviruses: A WHO Perspective', he shared insights on institutionalising wastewater surveillance for coronaviruses through the WHO CoViNet initiative. Dr Khairnar told TOI that Neeri plans to develop advanced technologies for wastewater-based epidemiology, including the use of artificial intelligence and machine learning algorithms to analyse wastewater data and predict disease outbreaks. PATH India's senior diagnostic lead, Praveen Kandasamy, discussed integrating Covid-19 testing infrastructure into broader pathogen surveillance systems. PATH Senegal experts Saikou Oumar Ba and Papa Sokhna highlighted strategies for maintaining national wastewater information dashboards. Experts in public health and epidemiology convened at Barvinok Village, Uzhgorod Region, Ukraine, to participate in the seminar. This event, aimed at advancing wastewater surveillance as a critical tool for public health, brought together over 60 govt officials from Ukraine, including epidemiologists and laboratory specialists from the regional Centres for Disease Control and Prevention, as well as representatives of the Ukrainian Public Health Centre. The seminar, supported by USAID and PATH Ukraine's ‘Support TB Efforts in Ukraine' project, featured diverse sessions led by renowned facilitators. Key speakers included Gunta Dravniece, project director at PATH Ukraine, and Dr Khairnar. On the second and third days, participants gained practical experience in wastewater surveillance across various Ukrainian regions, including Dnipropetrovsk, Lviv, Kyiv and Kharkiv. These sessions showcased achievements, challenges, and solutions drawn from regional experiences. The closing session summarised the seminar's outcomes, emphasising the next steps for scaling wastewater surveillance nationwide. With its focus on leveraging wastewater surveillance to monitor pathogens and improve public health responses, the seminar marked a pivotal moment for epidemiological advancements in Ukraine and beyond.